Key result
Resuming anticoagulation after gastrointestinal bleeding is associated with reduced thromboembolic events and mortality, with optimal timing suggested between 7 and 50 days despite a risk of rebleeding.
Why the study?
Data are limited to guide clinicians on resuming anticoagulation after hospitalization for gastrointestinal bleeding, and the optimal timing of resumption is unknown.
What is the optimal timing for restarting anticoagulation after hospitalization for gastrointestinal bleeding to balance risks of rebleeding, thromboembolism, and mortality?
What is the optimal timing for restarting anticoagulation after hospitalization for gastrointestinal bleeding to balance risks of rebleeding, thromboembolism, and mortality?
There is limited data to guide the optimal timing of resuming anticoagulation after gastrointestinal bleeding, highlighting a need for individualized patient management balancing bleeding and thrombotic risks.
May inform resumption decisions after GI bleeding; leaves optimal timing open for randomized trials.
Systemic anticoagulants are widely prescribed to prevent and treat thromboembolism, among other indications. A common complication of using these agents is gastrointestinal bleeding. While early resumption of anticoagulants after the bleeding has resolved can increase the risk of rebleeding, delayed resumption puts the patient at increased risk of thromboembolic events and mortality. There is limited data on this topic to guide clinicians on resuming anticoagulation after hospitalization for gastrointestinal bleeding and to educate patients regarding the subsequent risks of recurrent gastrointestinal bleeding, thromboembolism, and mortality. The optimal time to resume anticoagulation is also unknown. This review summarizes the existing literature and available data on the commonly encountered dilemma of restarting anticoagulation therapy after hospitalization for gastrointestinal bleeding.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2022) conducted a review in Gastrointestinal bleeding in patients requiring anticoagulation. Resumption of anticoagulation vs. Discontinuation or delayed resumption of anticoagulation was evaluated. Resuming anticoagulation after gastrointestinal bleeding is associated with reduced thromboembolic events and mortality, with optimal timing suggested between 7 and 50 days despite a risk of rebleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: